Mereo BioPharma Group plc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
London
SEC filing record 1 source field available
Fiscal year end
31 December
Mereo BioPharma Group plc has filed 433 SEC EDGAR filings since 01 Dec 2017

SEC filing history

Showing 51-75 of 433 matching filings.

Per page
25
Current page
3
ARS File 001-38452

ARS

Filing date
08 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38452

DEF 14A

Filing date
08 Apr 2025
Reporting date
13 May 2025
Next action
Verify source filing
SCHEDULE 13G File 005-91444

SCHEDULE 13G filing

Filing date
04 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91444

SCHEDULE 13G/A filing

Filing date
12 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jan 2025
Reporting date
25 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jan 2025
Reporting date
25 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jan 2025
Reporting date
25 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jan 2025
Reporting date
25 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jan 2025
Reporting date
25 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-284432

S-8

Filing date
23 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91444

SCHEDULE 13G/A filing

Filing date
06 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-283439

EFFECT filing

Filing date
04 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-283439

424B3

Filing date
04 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
03 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .